Treatment shows strong potential for ALK-driven neuroblastoma
A Phase I study has shown significant promise in treating newly diagnosed ALK-driven high-risk neuroblastoma in paediatric patients.
Source: europeanpharmaceuticalreview.com
Page 5 - Developmental Therapeutics Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Developmental Therapeutics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Developmental Therapeutics Program Today - Breaking & Trending Today
Plus Therapeutics Announces Patient Webinar in Recognition
Principal Investigator Dr. Andrew Brenner to Lead Musella Foundation Live Webinar...
Source: globenewswire.com
Cleveland Researchers Reveal New Strategy to Prevent Blood Clots without Increasing the Risk of Bleeding
A nanoparticle therapy developed by investigators at University Hospitals (UH) and Case Western Reserve University targets overactive neutrophils, a specific ki
Source: newswise.com
Research may lead to safer ways to care for patients impacted by blood clots
A nanoparticle therapy developed by investigators at University Hospitals (UH) and Case Western Reserve University targets overactive neutrophils, a specific kind of white blood cell, to prevent almost all types of blood clots while causing no increased risk for bleeding.
Source: news-medical.net
Research reveals why a large group of cancers are vulnerable to FDA-approved IDH1 inhibitors
A drug used to target IDH1 mutations in select cancers also appears to inhibit the wild-type form of the enzyme, under certain conditions.
Source: news-medical.net